Skip to content
Automated CRISPR engineering for antibody validation

Automated CRISPR engineering for antibody validation

Antibodies are fundamental to proteomic research and are widely-used immunodetection reagents. Recent concerns over scientific reproducibility as a result of non-specific, inconsistent antibody performance1 have focused efforts to thoroughly validate antibody reagents during development and before use in end-applications.

Knockout (KO) cell lines, where the target of interest has been edited out of the genome of human cell lines using CRISPR-Cas9, provide a permanent KO and a “gold standard” scalable model. Specific antibodies do not detect their target in validated KO cell lines and therefore serve as a true negative control.

In order to make a significant impact on improving the current reproducibility crisis, KO validation needs to be carried out at a scale relevant to the life sciences industry, which can be expedited by use of full, end-to-end automation for high-throughput (HT) KO cell line generation.

Download the resource to read on...

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.

Login

Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of qualify control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.